Skip to main content

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

National Institutes of Health

Not an open opportunity
Last verified: 2026-11-22

About This Grant

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD). Candidate interventions evaluated through this program, which can include small molecules or biologics for example, must engage non-amyloid/non-tau mechanisms and aim to address cognitive and/or neuropsychiatric symptoms in individuals across the spectrum from pre-symptomatic to more severe stages of disease. This NOFO uses the UG3/UH3 phased award mechanism and proposals must include prespecified, go/no-go safety and tolerability milestones that gate the advance from phase 1 to latter stages of clinical development.

Grant Summary

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) from National Institutes of Health: Not an open opportunity. FindGrants lists it for reference. Search open grants to find opportunities you can apply to now.

Not quite the right fit?

Search 1,500+ open grants, or get matches ranked for your organization — free.

Focus Areas

healthhealthcare

Eligibility

municipalityschool districtuniversitytribal governmentnonprofitsmall business

Requirements

  • must include prespecified, go/no-go safety and tolerability milestones that gate the advance from phase 1 to latter stages of clinical development

Record Details

Amount on Record

Not stated by funder

Complexity
Medium
This record is not an open grant opportunity, so it is not accepting applications. It is listed for reference; check the original source for current opportunities from this funder.

Related Grants